K-V Pharmaceutical Company (KV) is a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and markets branded and generic/non-branded prescription pharmaceutical products. The Company has a range of dosage form capabilities, including tablets, capsules, creams, liquids and ointments. KV conducts its branded pharmaceutical operations through Ther-Rx Corporation (Ther-Rx) and its generic/non-branded pharmaceutical operations through ETHEX Corporation (ETHEX). Through Particle Dynamics, Inc. (PDI), the Company also develops, manufactures and markets value-added raw material products for the pharmaceutical, nutritional, personal care, food and other markets. The Company has developed a variety of drug delivery and formulation technologies, which are primarily focused in four principal areas: SITE RELEASE; tastemasking; oral controlled release, and oral quick dissolving tablets.
Quick Financial Synopsis
BRIEF: For the three months ended 30 June 2008, K-V Pharmaceutical Company's revenues rose 30% to $148.9M. Net income totaled $12.5M, up from $6.2M. Revenues reflect increased income from Branded Products , Specialty Generics/ Non-branded and Specialty Materials segments. Net income also reflects higher operating margins, increased interest & other income and decrease in purchased in-process research and development expenses.
Company Address
K-V Pharmaceutical Company
2503 South Hanley Road St. Louis MO 63144
P: +1314.6456600 F: +1314.6442419